CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation
2013 ◽
Vol 11
(2)
◽
pp. 161-169
◽
2012 ◽
Vol 31
(3-4)
◽
pp. 807-814
◽
2015 ◽
Vol 22
(3)
◽
pp. 461-476
◽
2011 ◽
Vol 6
(6)
◽
pp. 1128-1131
◽
2017 ◽
Vol 49
(1)
◽
pp. 10-19
◽
2008 ◽
Vol 56
(3)
◽
pp. 97-103
◽
2008 ◽
Vol 26
(7)
◽
pp. 1182-1184
◽